加药联合阿格列汀/格列美脲治疗二甲双胍单药控制不佳2型糖尿病患者的效果对比研究

Abstract
Figure/Table
References (15)
Related Citation (12)

Download: PDF (0 KB) HTML (30 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo compare the efficacy between Alogliptin and Glimepiride in poorly controlledin patients with type 2 diabetes(T2DM)with oral Metformin.Methods60 in poorly controlled in patients with T2DM with oral Metformin in our hospital from March 2014 to March 2016 were randomized into two groups of receiving Alogliptin with Metformin(A group,30 cases)and Glimepiride with Metformin(B group,30cases)for 24 weeks.The changes of BMI,TC,G,HDL-C,LDL-C,FBG,HOMA-IR and Hypoglycemic were observed.ResultsAfter 24 weeks treatment,the FBG,2 h PG and HbA1c were significantly reduced compared with their pre-treatment(P＜0.05)in two groups,and there was significant difference between the two groups(P＜0.05).The HOMA-IR of the two groups were decreased significantly before treatment,but there was no significant difference between the groups(P＞0.05).The TC,TG,LDL-C and BMI of A group as bviously decreased and HDL-C was significantly increased than before treatment(P＜0.05),there was no significant difference in B group.There was no hypoglycemia occurs in A group,but two case was happened in B group.ConclusionCombined with Alogliptinor Glimepiridein poorly controlledin patients with T2DM with oral Metformin can significantly improve the patient′s blood glucose,body weight and insulin resistance.Different treatment options can be used depending on the patient′s differences.

Key words： Metformin Alogliptin Glimepiride Type 2 diabetes

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHONG Shu-mei
	ZHANG Si-qing

Cite this article:

ZHONG Shu-mei,ZHANG Si-qing. Comparison on Addingalogliptin or Glimepiride in poorly controlled in patients with type 2 diabetes with oral Metformin[J]. 中国当代医药, 2017, 24(32): 121-123.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I32/121

[1]	张璐，郭艺芳.2017年美国糖尿病学会糖尿病诊疗标准介绍[J].中华高血压杂志，2017，25（2）：130-131.
[2]	Shimpil RD，Patill PH，Kuchake VG，et al.Comparison of effect of metformin in comb-ination with glimepiride and glibenclamide onglycaemic control in patient with type 2 diabetes mellitus[J].Int J Pharm Tech Res，2009，1（1）：50-61.
[3]	张玉省，黄丽琴，王芳，等.口服二甲双胍血糖控制不佳的2型糖尿病患者联合沙格列汀治疗的效果与安全性研究[J].河北医科大学学报，2017，38（4）：458-461.
[4]	李文华，林梅，张晓洁.二甲双胍控制不佳的超重2型糖尿病患者加用西格列汀或格列美脲的疗效[J].中国医院药学杂志，2012，32（10）：792-794.
[5]	刘福平，张星光，陈彬.二甲双胍联合西格列汀或格列美脲对2型糖尿病血糖波动和氧化应激的影响[J].中国现代医学杂志，2015，25（33）：71-75.
[6]	叶丽萍.比较沙格列汀与格列美脲对使用二甲双胍继发失效的2型糖尿病的临床疗效[J].中华全科医学，2015，13（8）：1280-1282.
[7]	段小云，冯碧敏，张成斌，等.阿格列汀与其他口服降糖药比较治疗2型糖尿病的系统评价[J].中国新药与临床杂志，2017，36（4）：226-233.
[8]	Alberti KG，Zmmet PZ.Definition，diagnosis and classification of diabetes mellitus and its complications：report of a WHO Consultation.Part 1.Diagnosis and classification of diabetes mellitus[J].Diabet Med，1998，15（7）：539-553.
[9]	张蕾，柯瑞琼，欧阳灿晖，等，二甲双胍联合格列美脲治疗非酒精性脂肪肝合并2型糖尿病肥胖患者的效果观察[J].中国当代医药，2016，23（20）：132-134.
[10]	母义明，纪立农，宁光，等.二甲双胍临床应用专家共识（2016 年版）[J].中国糖尿病杂志，2016，24（10）：871-884.
[11]	梁菁菁，邹大进.二甲双胍控制不佳的2型糖尿病患者联合应用磷酸西格列汀的成本－效果分析[J].上海医学，2013，36（5）：414-417.
[12]	田勍，洪天配.美国糖尿病学会2017年版糖尿病医学诊疗标准的解读[J].中国糖尿病杂志，2017，25（7）：577-581.
[13]	柯瑞琼，秦永章，肖丽霞，等.加用格列美脲治疗单用预混胰岛素治疗血糖控制不佳肥胖2型糖尿病患者的临床观察[J].中国当代医药，2015，22（27）：91-93
[14]	马文婷.阿格列汀联合二甲双胍对2型糖尿病患者血糖控制及氧化应激指标的影响[J].中国处方药，2017，15（4）：88-89.
[15]	周岩，姬秋和．阿格列汀在2型糖尿病治疗中的研究进展[J].中华内分泌代谢杂志，2014，30（10）： 868-871.